Citius Pharmaceuticals Inc (CTXR)

Citius Pharmaceuticals Inc Stock (CTXR) Forecast

The Citius Pharmaceuticals Inc (CTXR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.40, representing a +595.69% increase from the current price of $0.4889. The highest analyst price target is $2.25, and the lowest is $4.55.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month CTXR Price Target

Average 8.50 (+1,638% Upside)

Is Citius Pharmaceuticals Inc (CTXR) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	45.77	Neutral
STOCH(9,6)	40.14	Neutral
STOCHRSI(14)	46.68	Neutral
MACD(12,26)	0.00	Buy
ADX(14)	32.53	Buy
William %R	-57.54	Neutral
CCI(14)	-31.18	Neutral

Buy: 2 · Sell: 0 · Neutral: 5Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	0.54 Sell	0.52 Sell
MA20	0.49 Sell	0.51 Sell
MA50	0.53 Sell	0.53 Sell
MA100	0.56 Sell	0.57 Sell
MA200	0.64 Sell	0.70 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, CTXR could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CTXR, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 45.77 indicates that CTXR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 40.14 indicates that CTXR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.68 indicates that CTXR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 32.53 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -31.18 indicates that CTXR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term CTXR price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Citius Pharmaceuticals Inc financial reports and earnings history, Citius Pharmaceuticals Inc (CTXR) stock could reach $14.58 by 2030, $67.11 by 2040 and $178.84 by 2050. See the projected annual prices until 2050 of the Citius Pharmaceuticals Inc stock below:

Citius Pharmaceuticals Inc (CTXR) is expected to reach an average price of $32.72 in 2035, with a high prediction of $34.03 and a low estimate of $19.19. This indicates an +6,593% change from the last recorded price of $0.4889.
Citius Pharmaceuticals Inc (CTXR) stock is projected to chart a bullish course in 2040, with an average price target of $51.12, representing an +10,356% change from its current level. The forecast ranges from a conservative $48.39 to a sky-high $67.11.
Our analysts predict Citius Pharmaceuticals Inc (CTXR) to change +18,913% by 2045, soaring from $91.53 to an average price of $92.95, potentially reaching $118.08. While $91.53 is the low estimate, the potential upside is significant.
Citius Pharmaceuticals Inc (CTXR) stock is expected to climb by 2050, reaching an average of $136.32, a +27,784% change from its current level. However, a wide range of estimates exists, with high and low targets of $178.84 and $136.82, respectively, highlighting the market's uncertainty.

Citius Pharmaceuticals Inc Stock (CTXR) Year by Year Forecast

Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2026

The predicted value for Citius Pharmaceuticals Inc (CTXR) in 2026 is set at an average of $1.22. Estimates vary from a peak of $2.25 to a trough of $0.2572, indicating an +148.76% surge from the present price of $0.4889.

Month	Average	Low	High	Change from today's price
December, 2026	$5.10	$4.55	$2.25	+943.10%

Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Citius Pharmaceuticals Inc (CTXR) is $9.81, with a high forecast of $16.57 and a low forecast of $0.4297. This indicates an +1,906% increase from the last price of $0.4889.

Month	Average	Low	High	Change from today's price
January, 2027	$5.49	$5.65	$3.37	+1,024%
February, 2027	$5.39	$7.34	$5.54	+1,002%
March, 2027	$4.38	$4.66	$3.41	+796.60%
April, 2027	$2.97	$0.4297	$6.32	+507.80%
May, 2027	$15.77	$2.47	$11.52	+3,126%
June, 2027	$17.29	$18.35	$16.57	+3,437%
July, 2027	$17.78	$17.28	$15.90	+3,538%
August, 2027	$16.24	$16.73	$15.88	+3,221%
September, 2027	$9.20	$15.13	$14.91	+1,782%
October, 2027	$5.35	$7.85	$6.00	+993.47%
November, 2027	$8.34	$7.19	$5.49	+1,606%
December, 2027	$9.48	$9.73	$8.61	+1,840%

Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2028

In 2028, Citius Pharmaceuticals Inc (CTXR) is projected to reach an average price of $4.63, with a high projection of $13.10 and a low estimate of $0.2627. This indicates an +846.18% rise from the last price of $0.4889.

Month	Average	Low	High	Change from today's price
January, 2028	$6.48	$7.23	$9.08	+1,225%
February, 2028	$14.22	$6.33	$6.87	+2,808%
March, 2028	$0.0185	$7.89	$13.10	-96.21%
April, 2028	$1.09	$0.5648	$3.34	+122.23%
May, 2028	$6.41	$3.76	$3.96	+1,211%
June, 2028	$1.70	$3.30	$6.60	+247.25%
July, 2028	$3.45	$1.00	$10.50	+606.48%
August, 2028	$1.81	$2.44	$3.86	+270.01%
September, 2028	$0.586	$0.2627	$4.41	+19.87%
October, 2028	$5.08	$1.03	$3.58	+939.54%
November, 2028	$5.03	$7.28	$5.13	+928.80%
December, 2028	$9.64	$6.32	$5.42	+1,872%

Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2029

The 2029 price forecast for Citius Pharmaceuticals Inc Stock (CTXR) is $6.05 on average, with a high prediction of $10.47 and a low estimate of $0.7451. This represents an +1,138% increase from the previous price of $0.4889.

Month	Average	Low	High	Change from today's price
January, 2029	$10.48	$11.11	$10.47	+2,044%
February, 2029	$8.01	$8.51	$8.20	+1,538%
March, 2029	$7.33	$7.69	$7.36	+1,399%
April, 2029	$6.88	$6.90	$5.80	+1,308%
May, 2029	$9.77	$7.59	$7.23	+1,898%
June, 2029	$5.69	$6.52	$8.89	+1,063%
July, 2029	$4.23	$5.48	$5.37	+764.41%
August, 2029	$4.47	$1.13	$3.12	+813.50%
September, 2029	$5.35	$5.87	$4.32	+995.03%
October, 2029	$6.32	$6.66	$5.47	+1,194%
November, 2029	$3.01	$6.81	$6.24	+516.15%
December, 2029	$1.10	$0.7451	$5.65	+125.73%

Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2030

Citius Pharmaceuticals Inc Stock (CTXR) is expected to reach an average price of $12.03 in 2030, with a high forecast of $14.58 and a low forecast of $6.14. This signifies an +2,362% surge from the last price of $0.4889.

Month	Average	Low	High	Change from today's price
January, 2030	$6.75	$6.14	$5.27	+1,280%
February, 2030	$6.88	$7.04	$5.95	+1,307%
March, 2030	$9.69	$8.53	$8.79	+1,882%
April, 2030	$14.69	$9.65	$11.92	+2,904%
May, 2030	$14.83	$14.75	$14.58	+2,933%
June, 2030	$13.19	$13.27	$13.55	+2,598%
July, 2030	$13.38	$13.52	$13.47	+2,636%
August, 2030	$13.96	$13.99	$13.94	+2,756%
September, 2030	$13.76	$13.61	$13.61	+2,715%
October, 2030	$13.33	$13.39	$13.53	+2,627%
November, 2030	$12.81	$12.82	$13.13	+2,521%
December, 2030	$11.15	$11.20	$12.40	+2,180%